Omnicell, Inc. (OMCL) — closed signal from October 30, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on January 28, 2026.
Predicted vs. what happened
What happened
Reached its target in 39 days.
The thesis — published October 30, 2025
Omnicell's stock has fallen a lot and may rebound around its upcoming earnings. There are signs sellers are tiring and momentum might improve, but recent business results are weak and one analyst urged selling. Expectations are low, so if costs drop and the product mix helps, shares could pop. Keep this a small, short-term trade with firm exit rules if the move goes the wrong way.
Primary drivers
- Shares look very beaten down, with early signs momentum may improve soon
- This week's earnings report could jolt the stock, prompting fast moves
- If management outlook improves, the stock could see quick relief
- Weak recent business trends limit confidence and may cap upside
How it played out
OMCL: target reached in 39 days
Lyra published OMCL at 32.99 on 2025-10-30 for a short-term window ending 2026-01-28. The thesis expected 30% growth, with a 42.89 target. It pointed to beaten-down shares, possible momentum improvement, an earnings report that could jolt the stock, and a chance that better management outlook could bring quick relief. It also said weak recent business trends limited confidence.
Inside the window, OMCL reached the target in 39 days. It later peaked at 55 on 2026-01-13, a 66.7% gain. It ended at 50.32. The thesis played out.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.